CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 57 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818,304 | +97.1% | 61,140 | +19.4% | 0.00% | – |
| Q2 2023 | $922,624 | +12.2% | 51,200 | 0.0% | 0.00% | – |
| Q1 2023 | $822,272 | -12.2% | 51,200 | 0.0% | 0.00% | – |
| Q4 2022 | $936,960 | -6.9% | 51,200 | 0.0% | 0.00% | – |
| Q3 2022 | $1,006,000 | +5.3% | 51,200 | 0.0% | 0.00% | – |
| Q2 2022 | $955,000 | +46.9% | 51,200 | +73.0% | 0.00% | – |
| Q1 2022 | $650,000 | -22.4% | 29,600 | +0.3% | 0.00% | – |
| Q4 2021 | $838,000 | +34.9% | 29,500 | 0.0% | 0.00% | – |
| Q3 2021 | $621,000 | +11.7% | 29,500 | 0.0% | 0.00% | – |
| Q2 2021 | $556,000 | +35.6% | 29,500 | +10.1% | 0.00% | – |
| Q1 2021 | $410,000 | +4.1% | 26,800 | -3.9% | 0.00% | – |
| Q4 2020 | $394,000 | -3.0% | 27,900 | +7.7% | 0.00% | – |
| Q3 2020 | $406,000 | -10.6% | 25,900 | 0.0% | 0.00% | – |
| Q2 2020 | $454,000 | +108.3% | 25,900 | +75.0% | 0.00% | – |
| Q1 2020 | $218,000 | -26.4% | 14,800 | +25.4% | 0.00% | – |
| Q4 2019 | $296,000 | +76.2% | 11,800 | +5.4% | 0.00% | – |
| Q3 2019 | $168,000 | -25.3% | 11,200 | +24.4% | 0.00% | – |
| Q2 2019 | $225,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $84,379,000 | 7.91% |
| RA Capital Management | 1,875,209 | $46,880,000 | 2.52% |
| Perceptive Advisors | 2,587,953 | $64,698,000 | 1.48% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $4,193,000 | 1.12% |
| Orbimed Advisors | 2,039,282 | $50,982,000 | 0.79% |
| Eventide Asset Management | 803,839 | $20,096,000 | 0.61% |
| Novo Holdings A/S | 135,009 | $3,375,000 | 0.47% |
| Opaleye Management Inc. | 36,000 | $900,000 | 0.27% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 490,000 | $12,250,000 | 0.03% |
| Baker Brothers Advisors | 132,985 | $3,325,000 | 0.02% |